Company
RheumaGen
- Business model
- B2B
Record updated 28 September 2026
About
RheumaGen is a preclinical cell and gene therapy company developing cures for autoimmune diseases by attacking them at their source: the Human Leukocyte Antigen (HLA) gene.
Company
Record updated 28 September 2026
RheumaGen is a preclinical cell and gene therapy company developing cures for autoimmune diseases by attacking them at their source: the Human Leukocyte Antigen (HLA) gene.
A first look at RheumaGen’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.